Foundation to Eradicate Duchenne

Call
Website
4202 Maple Tree Ct
Alexandria, VA 22304
+1 (703) 683-7500
https://duchennemd.org

The Foundation to Eradicate Duchenne is dedicated to advancing research and treatment options for Duchenne muscular dystrophy (DMD), a severe genetic disorder affecting muscle strength and function. The foundation plays a pivotal role in collaborative efforts that have led to the development and approval of AGAMREE, the first pharmacological intervention for DMD, by both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).

Through partnerships with various nonprofit organizations, government agencies, and academic institutions, the foundation has contributed to a comprehensive drug development program that emphasizes patient-focused research and innovative funding models. Their commitment to eradicating Duchenne muscular dystrophy continues to drive progress in the field, ensuring that future treatments benefit the affected communities.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Mesothelioma Applied Research Foundation

The Mesothelioma Applied Research Foundation is a non-profit organization based in Washington, DC that is dedicated to finding a cure for mesothelioma, a rare and aggressive form of cancer caused by asbestos exposure. They provide support to patients and families affected by mesothelioma, fund research projects, and raise awareness about the disease. Through their fundraising efforts, the foundation aims to advance treatment options and improve the quality of life for mesothelioma patients. They offer various ways for individuals to get involved, such as making donations, starting online fundraising pages, and sending out appeal letters to raise awareness and funds for research. The foundation also provides information about clinical trials, government funding, and resources for patients and families affected by mesothelioma.Generated from the website
Psychiatrists and psychoanalysts, Biological research, Medical research

Sequella Inc

Sequella Inc. is a clinical-stage pharmaceutical company based in Rockville, MD, focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline addresses significant global health threats, particularly tuberculosis and its multidrug-resistant forms, which impact billions of people worldwide. With two drug candidates having completed phase 2 clinical trials and additional candidates in preclinical development, Sequella aims to tackle various infectious diseases, including Helicobacter pylori infections and Clostridium difficile. Their research also explores treatments for non-tuberculous mycobacterial infections and parasitic diseases, demonstrating a commitment to addressing critical health challenges globally. Generated from the website

Osteogenesis Imperfecta Foundation, Inc

The Osteogenesis Imperfecta Foundation, Inc. (OIF) is a national health organization dedicated to improving the lives of individuals living with osteogenesis imperfecta (OI) through research, education, awareness, and mutual support. As the only voluntary organization of its kind, OIF offers resources designed to help both individuals affected by OI and medical professionals understand and manage this condition effectively. Through its various programs and initiatives, including the OI Information Center, support networks, and research opportunities, the OIF aims to foster community connections and promote scientific advancements in the understanding of OI. The organization's commitment to raising awareness and facilitating educational experiences is exemplified by its conferences, which bring together families and experts in the field. Generated from the website
United States›Virginia›Alexandria›Foundation to Eradicate Duchenne

Partial Data by Infogroup (c) 2025. All rights reserved.